Cite
Delta-9-tetrahydrocannabinol treatment results in a suppression of interleukin-2-induced cellular activities in human and murine lymphocytes
MLA
Kirk Trisler, and Steven Specter. “Delta-9-Tetrahydrocannabinol Treatment Results in a Suppression of Interleukin-2-Induced Cellular Activities in Human and Murine Lymphocytes.” International Journal of Immunopharmacology, vol. 16, July 1994, pp. 593–603. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e898ec6b116b888fd3f6e0913426eea8&authtype=sso&custid=ns315887.
APA
Kirk Trisler, & Steven Specter. (1994). Delta-9-tetrahydrocannabinol treatment results in a suppression of interleukin-2-induced cellular activities in human and murine lymphocytes. International Journal of Immunopharmacology, 16, 593–603.
Chicago
Kirk Trisler, and Steven Specter. 1994. “Delta-9-Tetrahydrocannabinol Treatment Results in a Suppression of Interleukin-2-Induced Cellular Activities in Human and Murine Lymphocytes.” International Journal of Immunopharmacology 16 (July): 593–603. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e898ec6b116b888fd3f6e0913426eea8&authtype=sso&custid=ns315887.